Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

ConditionsSpine Fracture Degenerative Disc Disease Spinal Instability Spinal Tumor Degenerative Myelopathy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAesculap AG

About this trial

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Eligibility criteria

Qualifiers

Patient is minimum 18 years old

Informed Consent in the documentation of clinical and radiological results

Patient has indication according to Instructions for Use (IFU)

Patient is not pregnant

Disqualifiers

Patient's clear unability or unwillingness to participate in follow-up examinations

Trial design

Treatments tested in this trial

posterior stabilization for the cervical spine

Treatment groups

200 Participants

are divided into 1 treatment group

Locations

Krankenhaus Ludmillenstift Meppen49716, MeppenLower Saxony, Germany

Städtisches Klinikum Dresden01076, DresdenSaxony, Germany

Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale06112, HalleSaxony-Anhalt, Germany

Schön Klinik Hamburg Eilbek22081, Hamburg Germany

Sponsors and collaborators

Aesculap AG

Lead sponsor

Raylytic GmbH

Collaborator

Source ClinicalTrials.gov